Can a probiotic tame hay fever? new study investigates
NCT ID NCT05208528
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested whether a probiotic called Bifidobacterium longum ES1, or its heat-treated version, could reduce symptoms of allergic rhinitis (hay fever) in 72 adults with moderate-to-severe dust mite allergies. Participants took daily capsules for several weeks and reported their symptoms and medication use. The goal was to see if these supplements could improve quality of life and reduce the need for rescue medicines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Bifidobacterium longum ES1 (a probiotic) and its heat-treated form (HT-ES1)
- What this could lead to
- If it works, this could point toward a natural supplement to help manage allergic rhinitis symptoms and reduce reliance on medication.
- What could go wrong
- This is a small, early-stage trial with only 72 participants. The effects may be modest or not better than a placebo, and results may not apply to everyone with allergies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eurecat
Reus, Reus, 43204, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient herbal blend put to the test against hay fever
- Can a pinpoint pollen dose unmask allergy triggers?
- Can an antihistamine–steroid combo pill beat standard allergy meds?
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Allergy study seeks to pinpoint those most bothered by cats and birch pollen
- Dog allergy vaccine shows promise in small swedish trial